Biogen
BIIB
885 hedge funds and large institutions have $72.5B invested in Biogen in 2014 Q4 according to their latest regulatory filings, with 130 funds opening new positions, 343 increasing their positions, 279 reducing their positions, and 54 closing their positions.
141% more first-time investments, than exits
New positions opened: 130 | Existing positions closed: 54
27% more funds holding in top 10
Funds holding in top 10: 41 → 52 (+11)
23% more repeat investments, than reductions
Existing positions increased: 343 | Existing positions reduced: 279
8% more funds holding
Funds holding: 819 → 885 (+66)
2% more capital invested
Capital invested by funds: $71.2B → $72.5B (+$1.32B)
17% less call options, than puts
Call options by funds: $1.13B | Put options by funds: $1.37B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$326M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$301M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$254M |
| 4 |
Goldman Sachs
New York
|
+$197M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$195M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.67B |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$241M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$223M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$199M |
| 5 |
CCI
Columbus Circle Investors
|
-$177M |
BIIB Hedge Fund Activity: Q4 2014 in Review
885 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q4 2014, worth a combined $72.5B — up 1.9% from $71.2B a quarter earlier.
Buyers outnumbered sellers: 130 funds opened new BIIB positions and 54 closed out — a net gain of 76 holders — while 343 added to existing stakes and 279 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $326M. The largest seller was Capital Research Global Investors, cutting an estimated $1.67B.
- 885 institutional investors held Biogen (BIIB) as of Q4 2014, up from 819 in Q3 2014.
- Funds reported $72.5B of Biogen stock for Q4 2014, up 1.9% quarter-over-quarter.
- 130 funds opened new Biogen positions in Q4 2014 and 54 closed out, a net change of +76 holders.
- The largest Biogen buyer in Q4 2014 was Wellington Management Group, an estimated $326M added.
- The largest Biogen seller in Q4 2014 was Capital Research Global Investors, an estimated $1.67B sold.
Based on aggregated 13F filings for Q4 2014.